SPAIN | ACTIS
06/11/2019
Lmite 08 May 2021
Oferta Tecnolgica
Ref.
TOIT20200504001
Development, identification and validation of COVID-19 prognostic and predictive biomarkers tests
A laboratory of an Italian university hospital developed selective chip-panels to detect COVID-19 susceptibility/resistance alleles. Panels are validated in terms of sensitivity, precision and specificity identifying at risk alleles according to clinical phenotypes. Industries or universities are sought for a technical cooperation to extend the product. Pharmaceutical companies or investors are sought for financial or license agreement to further develop the product in diagnostics.
Socios

logotipo CEOE Aragnlogotipo ITAINNOVAlogotipo Cmara Toledologotipo FEDAlogotipo UCLM
logotipo FUNDECYT-PCTEX logotipo ADERlogotipo FERlogotipo AINlogotipo UNAV

06/11/2019

Requerimientos: IE 6.0+, FF 1.5+ 1024x768+ | Aviso Legal | Confidencialidad

06/11/2019